ResearcherUniversity of California, San FranciscoActive in the last 2 years

Aditya Mahadevan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2834-5487; OpenAlex author ID A5049621046. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper

Papers 1

Replacing Liposomal Irinotecan With Standard Irinotecan in Pancreatic Adenocarcinoma: Should We Follow Suit and Substitute Without Dispute? Co-author DOI 10.1097/mpa.0000000000002490 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jennifer Brooke Valerin · 1 shared paper, 2025 · strength 0.37
- Paper Replacing Liposomal Irinotecan With Standard Irinotecan in Pancreatic Adenocarcinoma: Should We Follow Suit and Substit… DOI 10.1097/mpa.0000000000002490 ↗
Farshid Dayyani · 1 shared paper, 2025 · strength 0.37
- Paper Replacing Liposomal Irinotecan With Standard Irinotecan in Pancreatic Adenocarcinoma: Should We Follow Suit and Substit… DOI 10.1097/mpa.0000000000002490 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.